S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update

J Dtsch Dermatol Ges. 2012 Mar;10 Suppl 2:S1-95. doi: 10.1111/j.1610-0387.2012.07919.x.


Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque-type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Dermatologic Agents / administration & dosage*
  • Dermatology / standards*
  • Humans
  • Practice Guidelines as Topic*
  • Psoriasis / diagnosis*
  • Psoriasis / therapy*
  • Quality of Health Care*
  • Ultraviolet Therapy / standards*


  • Dermatologic Agents